Ontario expands use of biosimilar drug treatments

By Susan Yellin | Dec. 26, 2022, 9:53 a.m.

Photo: Unsplash | Laurynas Mereckas

Ontario Drug Benefit recipients who are on an originator biologic will begin to transition to a Health Canada approved biosimilar version of the drug at the end of March.

This article is reserved to PRO Level subscribers

Discover the PRO Level
Related topics …